Ignite Creation Date:
2024-05-06 @ 1:10 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03957031
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2019-05-17
Brief Title:
Gastric Cancer Risk Factors Associated With EU and CELAC Populations
Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Organization:
Fundación para la Investigación del Hospital Clínico de Valencia
Study Overview
Official Title:
Gastric Cancer Risk Factors Associated With EU and CELAC Populations
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
Recruiting
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LEGACY-1
Brief Summary:
The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis and controls defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i
Detailed Description:
GC is associated to several known risk factors Epidemiological and molecular features of GCs can vary widely The reasons behind these differences are multiple and complex and may include genetic susceptibility strains of the bacterium Helicobacter pylori H pylori Epstein Barr virus infection dietary factors and others These factors can influence GC outcomes There is little knowledge regarding how these risk factors are associated with GC in CELAC and EU populations
The primary objectives of this study are to
1 Identify risk factors associated with GC in the CELAC and EU populations participating in this study including Argentina Spain Mexico Netherlands Chile Portugal and Paraguay
2 Identify clinical demographic and epidemiological differences among the populations participating in this study
The primary objectives of this study are to
1 Identify risk factors associated with GC in the CELAC and EU populations participating in this study including Argentina Spain Mexico Netherlands Chile Portugal and Paraguay
2 Identify clinical demographic and epidemiological differences among the populations participating in this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None